Abstract
The ongoing coronavirus pandemic reached Mexico in late February 2020. Since then Mexico has observed a sustained elevation in the number of COVID-19 deaths. Mexico’s delayed response to the COVID-19 pandemic until late March 2020 hastened the spread of the virus in the following months. However, the government followed a phased reopening of the country in June 2020 despite sustained virus transmission. In order to analyze the dynamics of the COVID-19 pandemic in Mexico, we systematically generate and compare the 30-day ahead forecasts of national mortality trends using various growth models in near real-time and compare forecasting performance with those derived using the COVID-19 model developed by the Institute for Health Metrics and Evaluation. We also estimate and compare reproduction numbers for SARS-CoV-2 based on methods that rely on both the genomic data as well as case incidence data to gauge the transmission potential of the virus. Moreover, we perform a spatial analysis of the COVID-19 epidemic in Mexico by analyzing the shapes of COVID-19 growth rate curves at the state level, using techniques from functional data analysis. The early estimate of reproduction number indicates sustained disease transmission in the country with R∼1.3. However, the estimate of R as of September 27, 2020 is ∼0.91 indicating a slowing down of the epidemic. The spatial analysis divides the Mexican states into four groups or clusters based on the growth rate curves, each with its distinct epidemic trajectory. Moreover, the sequential forecasts from the GLM and Richards model also indicate a sustained downward trend in the number of deaths for Mexico and Mexico City compared to the sub-epidemic and IHME model that outperformed the others and predict a more stable trajectory of COVID-19 deaths for the last three forecast periods.
Author summary Mexico has been confronting the COVID-19 epidemic since late February under a fragile health care system and economic recession. The country delayed the implementation of social distancing interventions resulting in continued virus transmission in the country and reopened its economy in June 2020. In order to investigate the unfolding of the COVID-19 epidemic in Mexico and Mexico City the authors utilize the mortality data to generate and compare thirteen sequentially generated short-term forecasts using phenomenological growth models. Moreover, the reproduction number is estimated from genomic and time series data to determine the transmission potential of the epidemic, and spatial analysis using case incidence data is conducted to identify the characteristic growth patterns of the epidemic in different Mexican states including rapid increase in the growth rate followed by a rapid decline and slow growth rate followed by a rapid rise and a rapid decline. The best performing models indicate a more sustained transmission of the pandemic in Mexico. The forecasts generated from the GLM and Richards growth model indicate towards a sustained decline in the number of deaths whereas the sub-epidemic model and IHME model point towards a stable epidemic trajectory for forecasting periods as of August 23, 2020.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
G.C. is partially supported from NSF grants 1610429 and 1633381 and R01 GM 130900
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data for this study is publicly available
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos